testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel
- RxCUI
- 1597123
- RxNorm name
- testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel
- Display name
- testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel
- Full name
- testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:28
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Testosterone Gel, 1% | TESTOSTERONE GEL, 1% | Encube Ethicals, Inc. | 7d655d6d-01da-488c-bd4e-c7fbe0ace38c | 2025-10-08 | Boxed warning, Warnings, Adverse reactions | 1597123 |
| Testosterone | TESTOSTERONE | Actavis Pharma, Inc. | 5834d34f-839d-412c-b74c-da1dad2cfa88 | 2025-09-30 | Boxed warning, Warnings, Adverse reactions | 1597123 |
| Testosterone | TESTOSTERONE | Strides Pharma Science Limited | ee54c393-bcfe-4a52-b7b3-1da8750f35d9 | 2025-08-22 | Boxed warning, Warnings, Adverse reactions | 1597123 |
| Testosterone | TESTOSTERONE | Prasco Laboratories | 68b2375d-0365-4797-bc3d-63531c9f42fd | 2024-12-01 | Boxed warning, Warnings, Adverse reactions | 1597123 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f4e8fc4e-d6ba-2783-e053-2a95a90a7ae7 | testosterone 1 % Transdermal Gel, 2.5 GM | SY | 140 | These highlights do not include all the information needed to use ANDROGEL 1% safely and effectively. See full prescribing information for ANDROGEL 1%. ANDROGEL ® (testosterone gel) 1% for topical use CIII Initial U.S. Approval: 1953 | 20250731 |
| f4e8fc4e-d6ba-2783-e053-2a95a90a7ae7 | 2500 MG testosterone 0.01 MG/MG Topical Gel | SCD | 140 | These highlights do not include all the information needed to use ANDROGEL 1% safely and effectively. See full prescribing information for ANDROGEL 1%. ANDROGEL ® (testosterone gel) 1% for topical use CIII Initial U.S. Approval: 1953 | 20250731 |
| f4e8fc4e-d6ba-2783-e053-2a95a90a7ae7 | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel | PSN | 140 | These highlights do not include all the information needed to use ANDROGEL 1% safely and effectively. See full prescribing information for ANDROGEL 1%. ANDROGEL ® (testosterone gel) 1% for topical use CIII Initial U.S. Approval: 1953 | 20250731 |
| 5834d34f-839d-412c-b74c-da1dad2cfa88 | testosterone 1 % Transdermal Gel, 2.5 GM | SY | 21 | These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . Testosterone gel , for topical use CIII Initial U.S. Approval: 1953 | 20250930 |
| 5834d34f-839d-412c-b74c-da1dad2cfa88 | 2500 MG testosterone 0.01 MG/MG Topical Gel | SCD | 21 | These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . Testosterone gel , for topical use CIII Initial U.S. Approval: 1953 | 20250930 |
| 5834d34f-839d-412c-b74c-da1dad2cfa88 | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel | PSN | 21 | These highlights do not include all the information needed to use TESTOSTERONE GEL safely and effectively. See full prescribing information for TESTOSTERONE GEL . Testosterone gel , for topical use CIII Initial U.S. Approval: 1953 | 20250930 |
| 7d655d6d-01da-488c-bd4e-c7fbe0ace38c | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel | PSN | 8 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1%. TESTOSTERONE gel 1%, for topical use, CIII Initial U.S. Approval: 1953 | 20251008 |
| 7d655d6d-01da-488c-bd4e-c7fbe0ace38c | 2500 MG testosterone 0.01 MG/MG Topical Gel | SCD | 8 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1%. TESTOSTERONE gel 1%, for topical use, CIII Initial U.S. Approval: 1953 | 20251008 |
| 7d655d6d-01da-488c-bd4e-c7fbe0ace38c | testosterone 1 % Transdermal Gel, 2.5 GM | SY | 8 | These highlights do not include all the information needed to use TESTOSTERONE GEL, 1% safely and effectively. See full prescribing information for TESTOSTERONE GEL, 1%. TESTOSTERONE gel 1%, for topical use, CIII Initial U.S. Approval: 1953 | 20251008 |
| ee54c393-bcfe-4a52-b7b3-1da8750f35d9 | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel | PSN | 6 | These highlights do not include all the information needed to use TESTOSTERONE GEL 1% safely and effectively. See full prescribing information for TESTOSTERONE GEL 1%. TESTOSTERONE Gel 1%, for topical use CIII Initial U.S. Approval: 1953 | 20250822 |
| ee54c393-bcfe-4a52-b7b3-1da8750f35d9 | 2500 MG testosterone 0.01 MG/MG Topical Gel | SCD | 6 | These highlights do not include all the information needed to use TESTOSTERONE GEL 1% safely and effectively. See full prescribing information for TESTOSTERONE GEL 1%. TESTOSTERONE Gel 1%, for topical use CIII Initial U.S. Approval: 1953 | 20250822 |
| ee54c393-bcfe-4a52-b7b3-1da8750f35d9 | testosterone 1 % Transdermal Gel, 2.5 GM | SY | 6 | These highlights do not include all the information needed to use TESTOSTERONE GEL 1% safely and effectively. See full prescribing information for TESTOSTERONE GEL 1%. TESTOSTERONE Gel 1%, for topical use CIII Initial U.S. Approval: 1953 | 20250822 |
| 68b2375d-0365-4797-bc3d-63531c9f42fd | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel | PSN | 3 | These highlights do not include all the information needed to use Testosterone gel 1% safely and effectively. See full prescribing information for Testosterone gel 1%. Testosterone gel 1% for topical use CIII Initial U.S. Approval: 1953 | 20241201 |
| 68b2375d-0365-4797-bc3d-63531c9f42fd | testosterone 1 % Transdermal Gel, 2.5 GM | SY | 3 | These highlights do not include all the information needed to use Testosterone gel 1% safely and effectively. See full prescribing information for Testosterone gel 1%. Testosterone gel 1% for topical use CIII Initial U.S. Approval: 1953 | 20241201 |
| 68b2375d-0365-4797-bc3d-63531c9f42fd | 2500 MG testosterone 0.01 MG/MG Topical Gel | SCD | 3 | These highlights do not include all the information needed to use Testosterone gel 1% safely and effectively. See full prescribing information for Testosterone gel 1%. Testosterone gel 1% for topical use CIII Initial U.S. Approval: 1953 | 20241201 |
| d466910c-9a76-44e8-8759-4717ec2c591f | 2500 MG testosterone 0.01 MG/MG Topical Gel | SCD | 3 | These highlights do not include all the information needed to use AndroGel safely and effectively. See full prescribing information for AndroGel. AndroGel ® (testosterone gel) 1% for topical use CIII Initial U.S. Approval: 1953 | 20111215 |
| d466910c-9a76-44e8-8759-4717ec2c591f | testosterone 1 % Transdermal Gel, 2.5 GM | SY | 3 | These highlights do not include all the information needed to use AndroGel safely and effectively. See full prescribing information for AndroGel. AndroGel ® (testosterone gel) 1% for topical use CIII Initial U.S. Approval: 1953 | 20111215 |
| d466910c-9a76-44e8-8759-4717ec2c591f | testosterone 1 % (25 MG / 2.5 GM) Transdermal Gel | PSN | 3 | These highlights do not include all the information needed to use AndroGel safely and effectively. See full prescribing information for AndroGel. AndroGel ® (testosterone gel) 1% for topical use CIII Initial U.S. Approval: 1953 | 20111215 |